The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata (L. operculata), S. officinale (V. sabadilla), and Galphimia Glauca (G. glauca) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata (L. operculata) 10% extract MT, S. officinale (V. sabadilla) 3× extract, and Galphimia Glauca (G. glauca) 10% extract MT in a pharmaceutically acceptable carrier.
本公开描述了药物组合物和方法,用于减少人类普通感冒的持续时间、强度和/或困扰,以及减少表现出普通感冒症状(如鼻塞、流鼻涕、流眼泪、喉咙干/痒和打喷嚏)的严重程度或持续时间。本发明的组合物包含丝瓜(L. operculata)、S. officinale(V. sabadilla)和Galphimia Glauca(G. glauca)中至少一种在药学上可接受的载体中的
提取物,在不同的实施方案中,包含所有三种丝瓜(L. operculata)10%
提取物MT、S. officinale(V. sabadilla)10%
提取物MT、Galphimia Glauca(G. glauca)10%
提取物MT的混合物。operculata) 10%
提取物 MT、S. officinale (V. sabadilla) 3×
提取物和 Galphimia Glauca (G. glauca) 10%
提取物 MT 的混合物。